Latest News Archive
Please select Category, Year, and then Month to display items
23 September 2020
|
Story Nitha Ramnath
|
Photo Supplied
UFS students will be performing at the virtual ICDF on 24 September 2020.
On 24 September 2020, South Africa will be celebrating Heritage Day. For the 25th anniversary of this celebration, South Africans are encouraged to celebrate their culture and the diversity of their beliefs and traditions in the wider context of a country that belongs to all its people. Dr Chitja Twala, Vice-Dean: Faculty of the Humanities at the UFS, says: “The importance of the day is that we must celebrate who we are and learn from each other.” The University of the Free
State (UFS) has a long tradition of commemorating Heritage Day and the ideas underpinning it. One way in which the UFS celebrates and recognises the tapestry of diverse cultures represented on its campuses is through its International Cultural Diversity
Festival hosted by the Office for International Affairs. The purpose of the event is to highlight on Heritage Day that international cultural diversity is a central tenet of the UFS community.
Pursuant to the tremendous challenges caused by the COVID-19 pandemic globally, the International Cultural Diversity Festival will this year be celebrated in a virtual format. Even during this uncertain time, it is important to find time to celebrate
our uniqueness and to appreciate one another’s heritage and culture in the spirit of our humanity.
Date: 24 September 2020
Time: 10:00
No registration is required!
For the 2020 Heritage Month celebrations, let us share elements about ourselves that make us proud of who we are! The diverse contributions to the 2020 virtual International Cultural Diversity Festival activities will highlight the university’s commitment towards creating a diverse, challenging intellectual environment. As a research-led university, the UFS strives to provide an environment in which new ideas are incubated and debated, contributing to its transformation process and African unity.
For more information contact Bulelwa Moikwatlhai on MaloB@ufs.ac.za
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004